RESUMO
We tested associations between risk factors and bone mineral density in airways disease subjects, and developed a clinical screening tool to identify people who could benefit from bone mineral density testing. Subjects were recruited through hospital outpatients and pharmacies (Newcastle, n = 172). With survey refinement, we then tested a revised tool in a second sample (Adelaide, n = 317). Study factors included oral/inhaled corticosteroid use, asthma severity, respiratory admissions, physical activity, percent predicted forced expiratory volume in one second (FEV1), body mass index, and smoking history. Outcomes were bone mineral density of lumbar vertebra (L2-4) and total (or neck of) femur. Analysis was logistic regression with generation of a simple screening algorithm based upon coefficients. Scoring algorithm risk factors for T-score of < - 2.0: age > or = 68 = 10 points, bone mineral density < 20 = 25, weight < 60 kg = 20, 60-69 kg = 10, > or = 80 cigarette pack years = 15, low-level leisure activity = 5, area under receiver operator curve 0.83. For a cut-off score of 10, sensitivity was 91.2%, specificity 53.9%, positive and negative predictive values 52.3 and 91.7%, and 67.2% were correctly classified. In conclusions, our model has acceptable sensitivity, although limited specificity. Use of this tool may reduce unnecessary referrals for bone mineral density measurement.
Assuntos
Asma/complicações , Osteoporose/diagnóstico , Doença Pulmonar Obstrutiva Crônica/complicações , Absorciometria de Fóton , Adulto , Idoso , Densidade Óssea , Feminino , Humanos , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Osteoporose/complicações , Fatores de RiscoRESUMO
BACKGROUND: Patients with airways disease have been demonstrated to be at risk of osteoporosis, and this is likely to be multifactorial. Our aim was to identify patients with low bone mineral density (BMD) using a screening program, and then evaluate the benefit of daily alendronate. METHOD: Subjects with hip or lumbar spine baseline T-scores < - 2.5, or Z-score < - 1.0 commenced on alendronate/calcium (10 mg/600 mg day) or placebo/calcium, in a double blind randomized controlled trial. BMD by dual emission X-ray absorptiometry (lumbar vertebrae 2-4, neck of femur, total femur) was repeated after 12 months, with adverse events recorded. RESULTS: 145 subjects (74 male, 71 female, mean age 67, median FEV1 1.0 litres = 43% of predicted) were enrolled; 66 alendronate/calcium, 79 placebo/calcium with 24 and 26 withdrawals, respectively. Per protocol but not intention to treat analysis of covariance demonstrated statistically significant improvements in T and Z scores for lumbar spine bone mineral density (P = 0.035, P = 0.040), with no improvement demonstrated at the hip. CONCLUSIONS: Improvement in bone mineral density has been demonstrated at the lumbar spine, but not hip, by per protocol analysis, with daily alendronate, at 12 months.
Assuntos
Alendronato/uso terapêutico , Asma/complicações , Conservadores da Densidade Óssea/uso terapêutico , Densidade Óssea , Osteoporose/tratamento farmacológico , Doença Pulmonar Obstrutiva Crônica/complicações , Absorciometria de Fóton , Idoso , Asma/fisiopatologia , Feminino , Seguimentos , Volume Expiratório Forçado/fisiologia , Humanos , Vértebras Lombares/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Osteoporose/complicações , Osteoporose/metabolismo , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Resultado do TratamentoAssuntos
Artrite Reumatoide/complicações , Vacinas contra Influenza/efeitos adversos , Vasculite/complicações , Doença Aguda , Adulto , Angiografia , Artrite Reumatoide/diagnóstico por imagem , Feminino , Pé/diagnóstico por imagem , Mãos/diagnóstico por imagem , Humanos , Vasculite/diagnóstico por imagemRESUMO
Ankylosing spondylitis (AS) is a common and highly familial rheumatic disorder. The sibling recurrence risk ratio for the disease is 63 and heritability assessed in twins >90%. Although MHC genes, including HLA-B27, contribute only 20-50% of the genetic risk for the disease, no non-MHC gene has yet been convincingly demonstrated to influence either susceptibility to the disease or its phenotypic expression. Previous linkage and association studies have suggested the presence of a susceptibility gene for AS close to, or within, the cytochrome P450 2D6 gene (CYP2D6, debrisoquine hydroxylase) located at chromosome 22q13.1. We performed a linkage study of chromosome 22 in 200 families with AS affected sibling-pairs. Association of alleles of the CYP2D6 gene was examined by both case-control and within-family means. For case-control studies, 617 unrelated individuals with AS (361 probands from sibling-pair and parent-case trio families and 256 unrelated non-familial sporadic cases) and 402 healthy ethnically matched controls were employed. For within-family association studies, 361 families including 161 parent-case trios and 200 affected sibling-pair families were employed. Homozygosity for poor metabolizer alleles was found to be associated with AS. Heterozygosity for the most frequent poor metabolizer allele (CYP2D6*4) was not associated with increased susceptibility to AS. Significant within-family association of CYP2D6*4 alleles and AS was demonstrated. Weak linkage was also demonstrated between CYP2D6 and AS. We postulate that altered metabolism of a natural toxin or antigen by the CYP2D6 gene may increase susceptibility to AS.
Assuntos
Citocromo P-450 CYP2D6/genética , Espondilite Anquilosante/genética , Alelos , Estudos de Casos e Controles , Citocromo P-450 CYP2D6/metabolismo , DNA/genética , Saúde da Família , Feminino , Ligação Genética , Predisposição Genética para Doença , Genótipo , Humanos , Escore Lod , Masculino , Núcleo Familiar , Polimorfismo Genético , Espondilite Anquilosante/patologiaAssuntos
Antígenos HLA/imunologia , Antígenos HLA/metabolismo , Animais , Apresentação de Antígeno/imunologia , Antígenos HLA/química , Antígenos de Histocompatibilidade Classe I/biossíntese , Antígenos de Histocompatibilidade Classe II/biossíntese , Teste de Histocompatibilidade , Humanos , Doenças do Sistema Imunitário/imunologia , Camundongos , Modelos Moleculares , Terminologia como AssuntoRESUMO
The demographic, clinical, pathological and serological features of 123 decreased patients with systemic sclerosis have been analysed. These patients consisted of all identified patients dying with this disease in South Australia between 1983 and 1996 inclusive. There were 85 females and 38 males, with the ratio of limited:diffuse:overlap disease subset being 9:5:1. Disease characteristics revealed that patients with the limited disease tended to be female with high frequencies of the centromere autoantibody, while patients with the diffuse disease had equal gender representation with the frequent presence of nucleolar, speckled or homogeneous antinuclear antibody. Mean duration of disease and mean age of death for the limited:diffuse:overlap subsets differed significantly between groups (p < 0.05) and were 16.5, 9.3 and 10.9 years and 71.9, 57.8 and 52.8 years respectively. Cumulative survival curves for the subsets differed highly significantly, with patients with the limited diseases dying more commonly from right heart failure (documented terminally in 25% of the centromere positive limited subset), cardiovascular disease or cancer, while patients with the diffuse subset died from respiratory failure, renal failure or cardiovascular disease. In conclusion, this retrospective analysis has revealed that scleroderma is a relatively common but clinically heterogeneous disorder. There are important clinical and prognostic implications in defining limited versus diffuse versus overlap disease.
Assuntos
Sistema de Registros , Escleroderma Sistêmico/mortalidade , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Antinucleares/sangue , Causas de Morte , Centrômero/imunologia , Demografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Escleroderma Sistêmico/sangue , Escleroderma Sistêmico/patologia , Caracteres Sexuais , Austrália do Sul/epidemiologia , Taxa de SobrevidaRESUMO
The role of germline polymorphisms of the T-cell receptor A/D and B loci in susceptibility to ankylosing spondylitis was investigated by linkage studies using microsatellite markers in 215 affected sibling pairs. The presence of a significant susceptibility gene (lambda > or = 1.6) at the TCRA/D locus was excluded (LOD score < -2.0). At the TCRB locus, there was weak evidence of the presence of a susceptibility gene (P = 0.01, LOD score 1.1). Further family studies will be required to determine whether this is a true or false-positive finding. It is unlikely that either the TCRA/D or TCRB loci contain genes responsible for more than a moderate proportion of the non-MHC genetic susceptibility to ankylosing spondylitis.
Assuntos
Mutação em Linhagem Germinativa , Polimorfismo Genético , Receptores de Antígenos de Linfócitos T/genética , Espondilite Anquilosante/genética , Espondilite Anquilosante/imunologia , Saúde da Família , Feminino , Heterogeneidade Genética , Ligação Genética , Humanos , Masculino , Repetições de Microssatélites , Núcleo FamiliarRESUMO
OBJECTIVE: To localize the regions containing genes that determine susceptibility to ankylosing spondylitis (AS). METHODS: One hundred five white British families with 121 affected sibling pairs with AS were recruited, largely from the Royal National Hospital for Rheumatic Diseases AS database. A genome-wide linkage screen was undertaken using 254 highly polymorphic microsatellite markers from the Medical Research Council (UK) (MRC) set. The major histocompatibility complex (MHC) region was studied more intensively using 5 microsatellites lying within the HLA class III region and HLA-DRB1 typing. The Analyze package was used for 2-point analysis, and GeneHunter for multipoint analysis. RESULTS: When only the MRC set was considered, 11 markers in 7 regions achieved a P value of < or =0.01. The maximum logarithm of odds score obtained was 3.8 (P = 1.4 x 10(-5)) using marker D6S273, which lies in the HLA class III region. A further marker used in mapping of the MHC class III region achieved a LOD score of 8.1 (P = 1 x 10(-9)). Nine of 118 affected sibling pairs (7.6%) did not share parental haplotypes identical by descent across the MHC, suggesting that only 31% of the susceptibility to AS is coded by genes linked to the MHC. The maximum non-MHC LOD score obtained was 2.6 (P = 0.0003) for marker D16S422. CONCLUSION: The results of this study confirm the strong linkage of the MHC with AS, and provide suggestive evidence regarding the presence and location of non-MHC genes influencing susceptibility to the disease.
Assuntos
Testes Genéticos , Espondilite Anquilosante/genética , Mapeamento Cromossômico , Cromossomos Humanos Par 4/genética , Saúde da Família , Feminino , Ligação Genética , Marcadores Genéticos/genética , Predisposição Genética para Doença , Genoma Humano , Humanos , Doenças Inflamatórias Intestinais/genética , Escore Lod , Complexo Principal de Histocompatibilidade/genética , Masculino , Psoríase/genéticaRESUMO
OBJECTIVE: To analyze the effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis (AS). METHODS: Three hundred sixty-three white British AS patients were studied; 149 were carefully assessed for a range of clinical manifestations, and disease severity was assessed using a structured questionnaire. Limited HLA class I typing and complete HLA-DR typing were performed using DNA-based methods. HLA data from 13,634 healthy white British bone marrow donors were used for comparison. RESULTS: A significant association between DR1 and AS was found, independent of HLA-B27 (overall odds ratio [OR] 1.4, 95% confidence interval [95% CI] 1.1-1.8, P = 0.02; relative risk [RR] 2.7, 95% CI 1.5-4.8, P = 6 x 10(-4) among homozygotes; RR 2.1, 95% CI 1.5-2.8, P = 5 x 10(-6) among heterozygotes). A large but weakly significant association between DR8 and AS was noted, particularly among DR8 homozygotes (RR 6.8, 95% CI 1.6-29.2, P = 0.01 among homozygotes; RR 1.6, 95% CI 1.0-2.7, P = 0.07 among heterozygotes). A negative association with DR12 (OR 0.22, 95% CI 0.09-0.5, P = 0.001) was noted. HLA-DR7 was associated with younger age at onset of disease (mean age at onset 18 years for DR7-positive patients and 23 years for DR7-negative patients; Z score 3.21, P = 0.001). No other HLA class I or class II associations with disease severity or with different clinical manifestations of AS were found. CONCLUSION: The results of this study suggest that HLA-DR genes may have a weak effect on susceptibility to AS independent of HLA-B27, but do not support suggestions that they affect disease severity or different clinical manifestations.
Assuntos
Antígenos HLA-DR/genética , Espondilite Anquilosante/genética , Espondilite Anquilosante/fisiopatologia , Idade de Início , Artrite/genética , Predisposição Genética para Doença , Heterozigoto , Homozigoto , Humanos , Fatores de Risco , Espondilite Anquilosante/epidemiologiaRESUMO
We carried out a survival analysis of elbow synovectomy (ES) and excision of the radial head (RHE) performed on 171 rheumatoid elbows. The failure criteria were revision surgery (performed or desired) and/or the presence of significant or severe pain. The cumulative survival was 81% at one year which thereafter decreased by an average of 2.6% per year. The strongest predictor for success was a low preoperative range of supination-pronation when corresponding survival curves were compared. A low range of flexion-extension also predicted failure. Combining both factors gave better prediction (failure: 6.3% v 67%), but a long duration of elbow symptoms before surgery predicted failure (72%, p = 0.04). At review, there was a mean gain of 50 degrees in supination-pronation and 11 degrees in flexion-extension; both correlated with success. Failure correlated with recurrence of synovitis, elbow instability, ulnar neuropathy, poor general mobility and poor upper-limb function. The last was independently affected by the severity of RA in the ipsilateral shoulder. Our findings show that although the short-term result of ES and RHE in rheumatoid arthritis is good, the long-term outcome is poor except in a subgroup with more than 50% limitation of forearm rotation.
Assuntos
Artrite Reumatoide/cirurgia , Articulação do Cotovelo/cirurgia , Rádio (Anatomia)/cirurgia , Sinovectomia , Adulto , Idoso , Idoso de 80 Anos ou mais , Braço/fisiopatologia , Artrite Reumatoide/fisiopatologia , Articulação do Cotovelo/fisiopatologia , Feminino , Seguimentos , Previsões , Humanos , Instabilidade Articular/etiologia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Osteotomia , Dor Pós-Operatória/etiologia , Doenças do Sistema Nervoso Periférico/etiologia , Pronação/fisiologia , Amplitude de Movimento Articular/fisiologia , Recidiva , Reoperação , Estudos Retrospectivos , Articulação do Ombro/fisiopatologia , Supinação/fisiologia , Análise de Sobrevida , Sinovite/etiologia , Falha de Tratamento , Resultado do Tratamento , Nervo Ulnar/fisiopatologiaRESUMO
OBJECTIVE: To investigate the HLA class I associations of ankylosing spondylitis (AS) in the white population, with particular reference to HLA-B27 subtypes. METHODS: HLA-B27 and -B60 typing was performed in 284 white patients with AS. Allele frequencies of HLA-B27 and HLA-B60 from 5926 white bone marrow donors were used for comparison. HLA-B27 subtyping was performed by single strand conformation polymorphism (SSCP) in all HLA-B27 positive AS patients, and 154 HLA-B27 positive ethnically matched blood donors. RESULTS: The strong association of HLA-B27 and AS was confirmed (odds ratio (OR) 171, 95% confidence interval (CI) 135 to 218; p < 10(-99)). The association of HLA-B60 with AS was confirmed in HLA-B27 positive cases (OR 3.6, 95% CI 2.1 to 6.3; p < 5 x 10(-5)), and a similar association was demonstrated in HLA-B27 negative AS (OR 3.5, 95% CI 1.1 to 11.4; p < 0.05). No significant difference was observed in the frequencies of HLA-B27 allelic subtypes in patients and controls (HLA-B*2702, three of 172 patients v five of 154 controls; HLA-B*2705, 169 of 172 patients v 147 of 154 controls; HLA-B*2708, none of 172 patients v two of 154 controls), and no novel HLA-B27 alleles were detected. CONCLUSION: HLA-B27 and -B60 are associated with susceptibility to AS, but differences in HLA-B27 subtype do not affect susceptibility to AS in this white population.
Assuntos
Antígenos HLA-B/genética , Espondilite Anquilosante/genética , População Branca , Alelos , Sequência de Bases , Estudos de Casos e Controles , Suscetibilidade a Doenças , Antígeno HLA-B27/genética , Teste de Histocompatibilidade , Humanos , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Polimorfismo Conformacional de Fita SimplesRESUMO
We have undertaken a case referent study of the association between HLA allele frequency and specific IgE antibody to acid anhydride-human serum albumin (AA-HSA) conjugates among acid anhydride workers. Thirty cases with radio-allergosorbent test score versus AA-HSA conjugates > 2 were compared with 30 referents without specific IgE selected from the same factory sites as the cases and matched for age, sex, duration of exposure, atopic status, and smoking habit. We found a significant excess of HLA-DR3 in the cases with specific IgE to acid anhydrides when compared with the referents (50% versus 14%, Fisher's statistic = 8.4; odds ratio = 6, p = 0.05 corrected). The excess of HLA-DR3 was particularly associated with IgE versus trimellitic anhydride, with HLA-DR3 present in eight of 11 workers with and in two of 14 referents without IgE (Fisher's statistic = 8.5, odds ratio = 16, p = 0.004). The proportion of HLA-DR3 among the phthalic anhydride workers was not different in those with IgE (two of 12) from their referents (two of 14). These findings suggest MHC II proteins are an important determinant of the specificity of the IgE response to an inhaled hapten.
Assuntos
Poluentes Ocupacionais do Ar/efeitos adversos , Alérgenos/efeitos adversos , Especificidade de Anticorpos/efeitos dos fármacos , Antígeno HLA-DR3/efeitos dos fármacos , Imunoglobulina E/efeitos dos fármacos , Exposição Ocupacional/efeitos adversos , Anidridos Ftálicos/efeitos adversos , Adolescente , Adulto , Alelos , Especificidade de Anticorpos/genética , Frequência do Gene/efeitos dos fármacos , Frequência do Gene/genética , Antígeno HLA-DR3/sangue , Antígeno HLA-DR3/genética , Humanos , Imunoglobulina E/sangue , Imunoglobulina E/genética , Masculino , Pessoa de Meia-Idade , Exposição Ocupacional/estatística & dados numéricosRESUMO
In order to test for human histocompatibility leucocyte antigens (HLA) class II restriction of IgE responses, 431 subjects from 83 families were genotyped at the HLA-DR and HLA-DP loci and serotyped for IgE responses to six major allergens from common aero-allergen sources. A possible excess of HLA-DR1 was found in subjects who were responsive to Fel d I compared with those who were not (Odds Ratio (OR) = 2, P = 0.002), and a possible excess of HLA-DR4 was found in subjects responsive to Alt a I (OR = 1.9, P = 0.006). Increased sharing of HLA-DR/DP haplotypes was seen in sibling pairs responding to both allergens. Der p I, Der p II, Phl p V and Can f I were not associated with any definite excess of HLA-DR alleles. No significant correlations were seen with HLA-DP genotype and reactivity to any of the allergens. The results suggest class II HLA restriction is insufficient to account for individual differences in reactivity to common allergens.
Assuntos
Alérgenos/imunologia , Antígenos HLA-DP/genética , Antígenos HLA-DR/genética , Hipersensibilidade/imunologia , Imunoglobulina E/imunologia , Alelos , Frequência do Gene , Ligação Genética , Genótipo , Antígenos HLA-DP/imunologia , Antígenos HLA-DR/imunologia , Humanos , Reação em Cadeia da PolimeraseRESUMO
OBJECTIVES: The evaluation of the role of polymorphism within the class II encoded antigen processing genes, LMP2 and TAP, in susceptibility to ankylosing spondylitis (AS). METHODS: Eighty five patients with ankylosing spondylitis, 35 B27 positive healthy controls, and 55 unrelated healthy controls were studied. TAP1 and TAP2 alleles were assigned by ARMS PCR, and LMP2 alleles were assigned by restriction enzyme digestion of a PCR product. RESULTS: The TAP1C allele was increased in the AS group (6%) compared with random controls (1%), p = 0.03 and TAP2E was increased in AS (3.5%) compared with random controls (0%), p = 0.05. However, the frequencies of these alleles were also increased in B27 matched controls. There were no differences in LMP2 allele or genotype frequencies between AS and either of the control groups. Partitioning of patients according to presence or absence of uveitis did not reveal any significant associations. CONCLUSIONS: Increases of the minor TAP alleles, 1C and 2E, in AS reflect linkage disequilibrium between these alleles and HLA-B27. Polymorphism of the class I antigen processing pathway does not contribute significantly to AS susceptibility nor to the development of anterior uveitis associated with AS.
Assuntos
Transportadores de Cassetes de Ligação de ATP , Proteínas de Transporte/genética , Cisteína Endopeptidases , Genes MHC da Classe II/fisiologia , Antígenos de Histocompatibilidade Classe II/genética , Proteínas de Membrana/genética , Polimorfismo Genético/fisiologia , Proteínas/genética , Espondilite Anquilosante/genética , Membro 2 da Subfamília B de Transportadores de Cassetes de Ligação de ATP , Alelos , Aminoácidos/genética , Sequência de Bases , Suscetibilidade a Doenças , Genótipo , Antígeno HLA-B27/genética , Humanos , Desequilíbrio de Ligação , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Mapeamento por Restrição , Uveíte Anterior/genéticaAssuntos
Transportadores de Cassetes de Ligação de ATP , Alelos , Artrite Reumatoide/genética , Doenças Autoimunes/genética , Proteínas de Transporte/genética , Genes MHC da Classe II , Antígeno HLA-DR4/genética , Antígenos de Histocompatibilidade Classe II/genética , Complexo Principal de Histocompatibilidade , Membro 2 da Subfamília B de Transportadores de Cassetes de Ligação de ATP , Membro 3 da Subfamília B de Transportadores de Cassetes de Ligação de ATP , Artrite Reumatoide/imunologia , Doenças Autoimunes/imunologia , Frequência do Gene , Predisposição Genética para Doença , Humanos , Desequilíbrio de Ligação , Polimorfismo GenéticoRESUMO
Type 2 collagen is quantitatively the most important constituent of articular cartilage which is the target of progressive destruction in RA. Polymorphism of type 2 collagen could theoretically influence the development of RA either by rendering the cartilage matrix particularly susceptible to autoimmune attack or subsequent degradation. We have investigated the possibility that there is a common allele of type 2 collagen associated with RA by analysing a dimorphism of the corresponding structural gene (COL2A1) in healthy and diseased individuals. We compared haplotype frequencies, defined by the presence or absence of a Hind III restriction site at the COL2A1 locus (encoding type 2 collagen), in 98 patients with classical/definite RA and 158 controls. No differences were seen between the frequencies of individual genotypes in the two groups (maximum chi 2 = 0.7), indicating that susceptibility to this disease does not appear to be determined by the presence of a single common allelic variant at this locus.
Assuntos
Alelos , Artrite Reumatoide/genética , Colágeno/genética , Genes/genética , Sequência de Bases , Suscetibilidade a Doenças , Genótipo , Haplótipos/genética , Humanos , Dados de Sequência MolecularRESUMO
Acute polyarthritis is an important cause of morbidity in many tropical countries. Classification has often been difficult, with the term tropical polyarthritis used for those in whom a diagnosis could not be made. The implication that this is a distinct entity is probably incorrect, with likely causes being septic arthritis or post-infective reactive arthritis. This study aimed to determine the types of arthritis found in 43 patients (30 men) presenting consecutively to the Goroka Base Hospital in the Eastern Highlands of Papua New Guinea. Gonococcal arthritis was diagnosed in eight patients (six men) on the basis of isolation of Neisseria gonorrhoeae from the joint aspirate. In all cases the N gonorrhoeae was identified by the closed culture system on chocolate agar, but not always by routine plating. There were no specific clinical features that identified patients with a gonococcal septic arthritis. The remaining 34 patients had an undifferentiated oligoarthritis. The pattern of arthritis in men and women was of a lower limb pauciarticular arthritis with a predilection for the knee and ankle joints. A total of 30% of male patients had a history of urethral discharge and 44% of all patients had preceding diarrhoea. Arthritis was the only feature in 59% of patients and in 32% there was an associated enthesitis. In this study most patients had an oligoarthritis consistent with a reactive arthritis or a septic arthritis due to N gonorrhoeae. Broth inoculation of synovial fluid was the best method to isolate N gonorrhoeae, with standard methods for gonococcal isolation failing in some patients. It is recommended that the term 'tropical polyarthritis' is no longer used as it does not refer to a specific entity but consists of several known arthritides.
Assuntos
Artrite/diagnóstico , Clima Tropical , Doença Aguda , Adolescente , Adulto , Artrite/classificação , Artrite/etiologia , Artrite Infecciosa/diagnóstico , Artrite Infecciosa/etiologia , Feminino , Gonorreia/diagnóstico , Humanos , Masculino , Papua Nova GuinéRESUMO
There is a polygenic component to rheumatoid arthritis (RA) in addition to the known association with HLA-DR4. It has previously been shown in another autoimmune disease (type I diabetes mellitus) that a gene on chromosome 11p can act with HLA-DR4 to enhance susceptibility (relative risk 5-6). It is therefore possible that this locus may also affect the development of RA. Genotype frequencies at this locus, defined by a dimorphic Fok 1 restriction site, were compared in 139 healthy controls and 213 patients with classical/definite RA. In contrast with diabetes there was no increase in genotypes lacking the Fok 1 site, either in the rheumatoid group overall (125/211 compared with 86/139 controls) or in the DR4 positive rheumatoid group (76/140 compared with controls). These results indicate that the interaction between DR4 and a locus on chromosome 11p is not common to all DR4 associated autoimmune diseases.
Assuntos
Artrite Reumatoide/genética , Cromossomos Humanos Par 11 , Diabetes Mellitus Tipo 1/genética , Genes MHC da Classe II/genética , Antígeno HLA-DR4/genética , Sequência de Aminoácidos , Suscetibilidade a Doenças , Genótipo , Humanos , Dados de Sequência Molecular , Sondas de Oligonucleotídeos/químicaAssuntos
Genes MHC da Classe II , Antígenos HLA-DR/genética , Antígeno HLA-DR4/genética , Antígenos de Histocompatibilidade Classe II/genética , Miastenia Gravis/genética , Alelos , Sequência de Bases , Feminino , Antígeno HLA-DR7/genética , Cadeias HLA-DRB1 , Humanos , Pessoa de Meia-Idade , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Alinhamento de Sequência , Homologia de Sequência do Ácido NucleicoRESUMO
We have investigated the role of HLA-DR genotypes in 184 patients with severe rheumatoid arthritis (RA) and in 46 patients with Felty syndrome, to establish the relative contribution of the RA-associated subtypes of DR4 (Dw4, Dw14, and Dw15). There was an excess of DR4 homozygotes, particularly Dw4/Dw14 compound heterozygotes (relative risk [RR] 49). The risk associated with Dw4 depended on the other allele present--Dw4/DR1 (RR 21), Dw4/Dw4 (RR 15), and Dw4/DRX (RR 6). There was a significant risk from Dw4/Dw14 compared with Dw4/Dw4, both in those with severe RA (RR 2.9; P less than .02) and in those with Felty syndrome (RR 4.2; P less than .02). In contrast, in a further 63 known DR4 homozygotes with RA, not selected for severe disease, the excess of Dw4/Dw14 was much less striking (RR 1.4; not significant), suggesting that this genotype may be particularly associated with more severe disease. We also found four cases with the rare Dw4/Dw15 genotype (expected less than or equal to 0.5; P less than or equal to .02). Since the Dw4, Dw14, Dw15, and DR1 molecules have similar antigen-binding sites and since combinations of these alleles particularly predispose to severe RA, we suggest that synergistic mechanisms are involved. These could include an effect on T-cell repertoire selection.